Related Experiment Video

Updated: Jul 29, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Dystonia associated with carbamazepine administration: experience in brain-damaged children

C J Crosley, P T Swender

    Pediatrics
    |April 1, 1979
    PubMed

    Insights

    Carbamazepine, an anticonvulsant, can cause dystonia and opisthotonus in children. These movement disorders resolved after discontinuing carbamazepine, suggesting a link to dopamine antagonism.

    Area of Science:

    • Neurology
    • Pediatrics
    • Pharmacology

    Background:

    • Carbamazepine is a widely used anticonvulsant for epilepsy.
    • Treatment-resistant seizures in children often require aggressive pharmacotherapy.
    • Adverse neurological effects of anticonvulsants require careful monitoring.

    Observation:

    • Three pediatric patients with intractable seizures experienced dystonia and opisthotonus.
    • These movement disorders emerged 2-3 weeks after initiating carbamazepine therapy.
    • Symptoms resolved within 3 weeks of carbamazepine discontinuation, recurring upon re-challenge.

    Findings:

    • Carbamazepine use was temporally associated with the onset of dystonic symptoms in pediatric patients.
    • Discontinuation of carbamazepine led to the resolution of dystonia and opisthotonus.
    • The observed adverse effects suggest a potential dopamine antagonist mechanism of carbamazepine.

    Implications:

    • Clinicians should be aware of the potential for carbamazepine-induced movement disorders in children.
    • Monitoring for dystonia is crucial in pediatric patients receiving carbamazepine.
    • Further research into carbamazepine's dopaminergic effects may elucidate its adverse event profile.

    More Related Videos

    Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

    Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

    Published on: September 20, 2024

    Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale07:35

    Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

    Published on: July 8, 2025

    Related Concept Videos

    Depolarizing Blockers: Pharmocokinetics01:19

    Depolarizing Blockers: Pharmocokinetics

    Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
    Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

    Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

    Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
    The binding of dantrolene to the RYR1...
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
    Tetanus01:29

    Tetanus

    Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
    Alterations in Muscle Tone ll01:12

    Alterations in Muscle Tone ll

    Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
    Alterations in Muscle Tone lll01:11

    Alterations in Muscle Tone lll

    Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...